Search results for "Tension"

showing 10 items of 2456 documents

Association between early-stage chronic kidney disease and reduced choroidal thickness in essential hypertensive patients.

2018

The introduction in the past few years of advanced optical coherence tomography (OCT) techniques has greatly increased our understanding of the choroid, which is the most important vascular layer of the eye. Our study aimed to assess choroidal thickness by using swept-source OCT (SS-OCT) in essential hypertensive patients (EHs) with and without early-stage chronic kidney disease (CKD). We enrolled 100 EHs, of whom 65 were without kidney damage, and 35 had stage 1-3 CKD. In all of the participants, SS-OCT and a routine biochemical workup were performed. Glomerular filtration rate (GFR) was estimated by the CKD Epidemiology Collaboration equation (eGFR). CKD was defined in agreement with the …

AdultMalemedicine.medical_specialtyPhysiologyUrologyRenal function030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRenal damageInternal MedicinemedicineHumans030212 general & internal medicineProspective StudiesRenal Insufficiency ChronicAgedKidneyHypertensive eye diseasebusiness.industryChoroidMicrocirculationConfoundingDiabetic retinopathyOdds ratioMiddle Agedmedicine.diseaseeye diseasesConfidence intervalmedicine.anatomical_structureRenal dysfunctionFemalesense organsChoroidEssential HypertensionCardiology and Cardiovascular MedicinebusinessTomography Optical CoherenceKidney diseaseHypertension research : official journal of the Japanese Society of Hypertension
researchProduct

Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.

2006

The objective of the present study was to assess factors related to long-term changes in urinary albumin excretion (UAE) of nondiabetic microalbuminuric (n = 252) or proteinuric hypertensive individuals (n = 58) in a prospective follow-up.After enrollment, patients were placed on usual care including nonpharmacological treatment and/or treatment with an antihypertensive drug regime to achieve blood pressure135/85 mmHg. Periodic UAE measurements were performed until regression or significant reduction (defined when UAE dropped50% from the initial values, plus reduction of UAE to30 mg/24 h for microalbuminuric patients and300 mg/24 h for proteinuric patients).Among the microalbuminuric patien…

AdultMalemedicine.medical_specialtyPhysiologymedicine.drug_classAdrenergic beta-AntagonistsUrologyRenal functionAngiotensin-Converting Enzyme InhibitorsBlood PressureEssential hypertensionExcretionInternal medicineInternal MedicinemedicineAlbuminuriaHumansAntihypertensive drugbusiness.industryProportional hazards modelHazard ratioMiddle Agedmedicine.diseaseCalcium Channel BlockersConfidence intervalEndocrinologyBlood pressureHypertensionFemaleCardiology and Cardiovascular MedicinebusinessAngiotensin II Type 1 Receptor BlockersFollow-Up StudiesGlomerular Filtration RateJournal of hypertension
researchProduct

Plasma noradrenaline and the pressor action of exogenous noradrenaline in normotensive subjects and patients with essential hypertension.

1978

1. An inverse relationship was found between plasma noradrenaline and reactivity to exogenous noradrenaline in normotensive subjects. 2. The relationship between plasma noradrenaline and reactivity was disturbed in age-matched patients with essential hypertension. 3. A multiple-regression analysis showed a highly significant correlation between adrenergic activity and reactivity to noradrenaline and the mean arterial blood pressure level (r = 0·91). The results suggest that adrenergic activity and pressor response to noradrenaline combined are important determinants of arterial blood pressure. 4. An inverse relationship could also be demonstrated between plasma renin activity and reactivity…

AdultMalemedicine.medical_specialtyPlasma noradrenalinebusiness.industryAngiotensin IIAdrenergicBlood PressureGeneral MedicineEssential hypertensionmedicine.diseasePlasma renin activityAngiotensin IINorepinephrineEndocrinologyBlood pressurePressor responseInternal medicineHypertensionReninmedicineHumansFemalebusinessClinical science and molecular medicine. Supplement
researchProduct

Angiotensin II antagonists - an assessment of their acute toxicity.

2013

In Germany, increasing prescription rates of angiotensin II antagonists resulted in rising enquiries to Poisons Information Centres (PICs) during the last decade. Therefore, we aimed to assess their acute toxicity for deriving triage recommendations.An observational case series with data collected retrospectively from eight PICs in Austria, Germany and Switzerland. Inclusion criteria were monoexposure, defined dose, and documented follow-up.In total, 206 cases of exposures to angiotensin II antagonists were included (candesartan, 94; eprosartan, 3; irbesartan, 20; losartan, 26; olmesartan, 16; telmisartan, 18; and valsartan, 29). The median dose expressed as a multiple of their maximum dail…

AdultMalemedicine.medical_specialtyPoison Control CentersTime FactorsPharmacologyToxicologyIrbesartanInternal medicineGermanymedicineHumansAntihypertensive AgentsRetrospective Studiesbusiness.industryPoisoningEprosartanGeneral MedicineMiddle AgedAngiotensin IILosartanValsartanChild PreschoolMedian bodyFemaleTelmisartanDrug OverdoseHypotensionbusinessOlmesartanAngiotensin II Type 1 Receptor Blockersmedicine.drugClinical toxicology (Philadelphia, Pa.)
researchProduct

Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population

2011

BACKGROUND: We aim to study the prevalence of metabolic syndrome (MS), hypertension and diabetes, and their relationship to cardiovascular disease in subjects with hypertriglyceridemia. METHODS: This is an observational cross-sectional study, uncontrolled and multicentre study. Selected subjects were patients with hypertriglyceridemia (triglycerides, TG, ≥ 200 mg/dl) visited in the Lipid Units of the Spanish Arteriosclerosis Society who met the inclusion criteria. Prevalence of MS (ATPIII and IDF criteria, MS-ATPIII or MS-IDF), hypertension and diabetes were studied. The presence of cardiovascular disease (CVD) was also determined. RESULTS: The results showed that individuals referred for h…

AdultMalemedicine.medical_specialtyPopulationDiseaseDiabetes ComplicationsRisk FactorsInternal medicineDiabetes mellitusDiabetes MellitusPrevalenceInternal MedicinemedicineHumansIn patienteducationAgedHypertriglyceridemiaMetabolic Syndromeeducation.field_of_studybusiness.industryHypertriglyceridemianutritional and metabolic diseasesArteriosclerosisMiddle Agedmedicine.diseaseCross-Sectional StudiesCardiovascular DiseasesSpainHypertensionCardiologyFemaleObservational studyMetabolic syndromebusinessEuropean Journal of Internal Medicine
researchProduct

Prevalence of distress, comorbid conditions and well being in the general population.

2011

Abstract Background The purposes of this paper are to determine the prevalence of distress in the community, to identify its determinants and to assess its relationship to somatic conditions and subjective well being. Methods Distress and associated factors were investigated in a random sample of 5000 participants (35–74 years) of a community-based, prospective, observational cohort study in western Mid-Germany (“Gutenberg Heart Study”) between 04/2007 and 10/2008. The sample was stratified 1:1 for gender and residence and in equal strata for decades of age. Data were assessed by self-report instruments, interviews and medical examination. Results We found a prevalence rate for depression o…

AdultMalemedicine.medical_specialtyPopulationMyocardial InfarctionCoronary DiseaseComorbidityAnxietyPersonality DisordersMental distressResidence CharacteristicsGermanymedicineDiabetes MellitusPrevalenceHumansObesityProspective StudiesPsychiatryeducationDepression (differential diagnoses)AgedDyslipidemiaseducation.field_of_studyDepressionType D personalitySocial anxietyMiddle AgedStrokePsychiatry and Mental healthClinical PsychologyDistressMental HealthHypertensionAnxietyPanic DisorderFemalemedicine.symptomPsychologyStress PsychologicalCohort studyJournal of affective disorders
researchProduct

Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertensio…

2010

Abstract Background The Escarval-Risk study aims to validate cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia living in the Valencia Community, a European Mediterranean region, based on data from an electronic health recording system comparing predicted events with observed during 5 years follow-up study. Methods/Design A cohort prospective 5 years follow-up study has been designed including 25000 patients with hypertension, diabetes and/or dyslipidemia attended in usual clinical practice. All information is registered in a unique electronic health recording system (ABUCASIS) that is the usual way to register clinical practice in the Valencian Health System…

AdultMalemedicine.medical_specialtyPopulationRisk AssessmentCohort StudiesStudy ProtocolEnvironmental healthEpidemiologyDiabetes MellitusmedicineHumansProspective StudieseducationAgedDyslipidemiasAged 80 and overeducation.field_of_studyMediterranean Regionbusiness.industrylcsh:Public aspects of medicinePublic healthPublic Health Environmental and Occupational Healthlcsh:RA1-1270Middle Agedmedicine.diseaseCardiovascular DiseasesHypertensionCohortPhysical therapyFemaleBiostatisticsRisk assessmentbusinessDyslipidemiaCohort studyBMC Public Health
researchProduct

Risk factors associated with retinal vein occlusion

2014

Summary Aims Retinal vein occlusion (RVO) is the most frequent retinal vascular disease after diabetic retinopathy in which arterial risk factors are much more relevant than venous factors. The objective was to evaluate the role of risk factors in the development of the first episode of RVO. Subjects and Methods One hundred patients with RVO [mean age 56 years, 42% females and mean body mass index (BMI) 27.5 kg/m2] were recruited consecutively from the outpatient clinic of a tertiary hospital in Valencia (Spain). All subjects underwent clinical assessment including anthropometric and blood pressure measurements and laboratory test including homocysteine, antiphospholipid antibodies (aPLAs) …

AdultMalemedicine.medical_specialtyPopulationThrombophiliaRisk FactorsInternal medicineRetinal Vein OcclusionPrevalencemedicineHumansThrombophiliaOutpatient clinicObesityeducationAgedDyslipidemiasFirst episodeeducation.field_of_studybusiness.industryVascular diseaseCarotid ultrasonographyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryBlood pressureSpainHypertensionCohortFemalebusinessInternational Journal of Clinical Practice
researchProduct

Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study.

2015

SummaryObjective To determine the age- and sex-specific prevalence and determinants of retinal vein occlusions (RVOs) in a large population-based German cohort. Methods The investigation included 15 010 participants (aged 35–74 years) from the Gutenberg Health Study. We determined the prevalence of RVO (central retinal vein occlusion [CRVO] and branch retinal vein occlusion [BRVO]) for the local population by assessing fundus photographs of 12 954 (86.3%; 49.8% women and 50.2% men) participants. Further, we analyzed the associations of RVO with cardiovascular, anthropometric, and ophthalmic parameters. Results The weighted prevalences of RVO, CRVO, and BRVO were 0.40%, 0.08%, and 0.32%, res…

AdultMalemedicine.medical_specialtyPopulationVision DisordersVisual AcuitySex FactorsCentral retinal vein occlusionRisk FactorsInternal medicineGermanyAtrial FibrillationRetinal Vein OcclusionmedicineOdds RatioPrevalenceHumansRisk factorFamily historyeducationStrokeAgededucation.field_of_studybusiness.industryAge FactorsHematologyOdds ratioMiddle Agedmedicine.diseaseeye diseasesSurgeryStrokeLogistic ModelsPhenotypeCohortHypertensionBranch retinal vein occlusionFemalebusinessJournal of thrombosis and haemostasis : JTH
researchProduct

Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion.

2021

Non-cirrhotic portal vein thrombosis (PVT) in patients with antiphospholipid syndrome (APS) is a rare complication, and the management has to be determined individually based on the extent and severity of the presentation. We report on a 37-year-old male patient with non-cirrhotic chronic PVT related to a severe thrombophilia, comprising APS, antithrombin-, factor V- and factor X-deficiency. Three years after the initial diagnosis of non-cirrhotic PVT, the patient presented with severe hemorrhagic shock related to acute bleeding from esophageal varices, requiring an emergency transjugular intrahepatic portosystemic stent shunt (TIPSS). TIPSS was revised after a recurrent bleeding episode du…

AdultMalemedicine.medical_specialtyPortal venous pressuremedicine.medical_treatment030204 cardiovascular system & hematologyThrombophiliaEsophageal and Gastric Varices03 medical and health sciences0302 clinical medicineEsophageal varicesHypertension PortalmedicineHumansThrombophiliaEmbolizationPatient Care TeamVenous Thrombosisbusiness.industryPortal VeinGastroenterologymedicine.diseaseThrombosisSurgeryPortal vein thrombosisPortal hypertension030211 gastroenterology & hepatologyStentsPortasystemic Shunt Transjugular IntrahepaticbusinessVaricesGastrointestinal HemorrhageZeitschrift fur Gastroenterologie
researchProduct